Full Text View
Tabular View
No Study Results Posted
Related Studies
Subcutaneous Administration of Otelixizumab to T1DM Patients (RAO112438)
This study has been completed.
Study NCT00946257   Information provided by GlaxoSmithKline

First Received on July 23, 2009.   Last Updated on May 29, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial